Metronidazole as Preoperative Therapy in CRC / FusoMetro-001

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Colorectal Cancer

Interventions

DRUG

Metronidazole Oral

Metronidazole will be administered per os at 500 mg x 3/day, for 10 days prior to surgery.

Trial Locations (1)

RECRUITING

Oncology Institute of Southern Switzerland, Bellinzona

All Listed Sponsors

lead

Oncology Institute of Southern Switzerland

OTHER